Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI).

ABSTRACT: Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI).

PROVIDER: PRJNA408268 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI).

Project description:In this study, the effect of arginine deprivation on global gene expression in MDA-MB-231 and its ρ0 cells were examined. MDA-MB-231 ρ0 cells lack mitochondrial DNA and therefore have impaired OXPHOS function. Both parental and ρ0 cells were cultured in complete or arginine depleted medium for 48 hours. Comparative transcriptome analysis of both cell lines in complete growth medium versus arginine depleted medium were performed.

2018-11-02 | GSE104105 | GEO

Evolutionary insights reveal a new role of peptidyl arginine deiminase 2 in transcription regulation

Project description:Evolutionary insights reveal a new role of peptidyl arginine deiminase 2 in transcription regulationA systematic evolutionary analysis identified positively selected residues in the non-catalytic domain of PADI2. We established a link between the positive evolution of key residues in the PADI2 and their role in transcription. Specifically, we identified the structurally exposed loop encompassing the positively selected L162 in the PADI2 middle domain and its role in transcription and cellular proliferation. This loop contributes to the PADI2 interaction with the P-TEFb complex and cellular proliferation. Our results showcase the use of combining evolutionary and experimental approaches to dissect the dynamic of evolutionary processes.

2024-03-15 | GSE246420 | GEO

Exploiting Arginine Auxotrophy with Pegylated Arginine Deiminase (ADI-PEG20) to Sensitize Pancreatic Cancer to Radiotherapy via Metabolic Dysregulation.

Project description: Not available

| S-EPMC6891156 | biostudies-literature

Characterization of Gene Expression in ASS1-Deficient Breast Cancer Cells

Project description:Analysis of mechanism underlying the metabolic effects of ADI-PEG20 at gene expression level. The hypothesis tested in the present study was that ASS1-deficient breast cancer cells would be arginine-auxotrophs and would therefore be sensitive to arginine starvation. Results provide important information of the response of ASS1-deficient breast cancer cells to ADI-PEG20-treatment, such as the suppression of mRNAs encoding mitochondrial respiratory chain proteins. Total RNA obtained from ADI-treated, or ADI- and L-arginine-treated 231 cells compared to untreated cells.

2014-05-20 | E-GEOD-53838 | biostudies-arrayexpress

Brachypodium distachyon strain:Adi-9 | cultivar:Adi-9

Project description:Brachypodium distachyon strain:Adi-9 | cultivar:Adi-9 Genome sequencing

| PRJNA333717 | ENA

Brachypodium distachyon strain:Adi-4 | cultivar:Adi-4

Project description:Brachypodium distachyon strain:Adi-4 | cultivar:Adi-4 Genome sequencing

| PRJNA333716 | ENA

Brachypodium distachyon strain:Adi-15 | cultivar:Adi-15

Project description:Brachypodium distachyon strain:Adi-15 | cultivar:Adi-15 Genome sequencing

| PRJNA334171 | ENA

Hypoxia-induced nitric oxide production and tumour perfusion is inhibited by pegylated arginine deiminase (ADI-PEG20).

Project description: Not available